ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,197Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 1844

$1.5M Total Retail Price of All Prescriptions

Rank: 10 out of 1844

616 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 20,560 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 773 697 S3 1 2
OMEPRAZOLE 641 581 2 5
FUROSEMIDE 636 615 3 7
AMLODIPINE BESYLATE 603 564 4 6
SIMVASTATIN 601 519 5 3
NAMENDA 547 504 6 33
POTASSIUM CHLORIDE 530 501 7 16
LEVOTHYROXINE SODIUM 513 483 8 1
TRAMADOL HCL 471 412 9 18
DONEPEZIL HCL 409 386 10 26
METOPROLOL TARTRATE 372 312 11 11
POLYETHYLENE GLYCOL 3350 370 311 12 39
LISINOPRIL 331 316 13 4
ATENOLOL 305 274 14 17
WARFARIN SODIUM 265 232 15 13
TRIAMTERENE-HCTZ 263 236 16 48
LIDODERM 259 226 17 155
MIRTAZAPINE 258 256 18 49
GABAPENTIN 251 189 19 15
GLIMEPIRIDE 241 235 20 35
ZOLPIDEM TARTRATE 232 217 21 23
ISOSORBIDE MONONITRATE ER 217 212 22 59
METFORMIN HCL ER 213 201 23 46
ROPINIROLE HCL 208 206 24 76
ESCITALOPRAM OXALATE 206 166 25 52
MELOXICAM 200 189 26 28
RISPERIDONE 189 137 27 65
CLOPIDOGREL 187 159 28 34
ATORVASTATIN CALCIUM 181 161 29 12
DOXYCYCLINE HYCLATE 176 157 30 90
DIGOXIN 175 163 31 67
DIVALPROEX SODIUM 175 156 31 74
HYDRALAZINE HCL 174 156 33 120
CYMBALTA 171 121 34 36
TAMSULOSIN HCL 170 141 35 27
ALLOPURINOL 169 158 36 29
PANTOPRAZOLE SODIUM 159 137 37 32
ALENDRONATE SODIUM 156 150 38 25
CARBIDOPA-LEVODOPA 154 154 39 86
BACLOFEN 152 110 40 119
METFORMIN HCL 146 124 41 8
FENTANYL 138 136 S2 42 66
NOVOLOG 136 127 43 84
LANTUS 134 122 44 42
EXELON 133 133 45 112
DICLOFENAC SODIUM 123 120 46 122
CYCLOBENZAPRINE HCL 121 102 R 47 53
METOCLOPRAMIDE HCL 117 105 48 148
METOPROLOL SUCCINATE 116 116 49 14
LEVETIRACETAM 116 83 49 105
RANITIDINE HCL 114 101 51 38
BENAZEPRIL HCL 112 111 52 75
BYSTOLIC 110 108 53 106
PLAVIX 105 91 54 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 100 55 20
TRAZODONE HCL 103 90 56 43
LYRICA 103 67 56 92
NEXIUM 99 97 58 31
PROMETHAZINE HCL 99 71 R 58 88
OXYBUTYNIN CHLORIDE ER 97 97 60 126
CLONIDINE HCL 91 71 61 64
IPRATROPIUM-ALBUTEROL 91 89 61 113
ATENOLOL-CHLORTHALIDONE 89 76 63 156
JANUVIA 88 68 64 77
PHENYTOIN SODIUM EXTENDED 88 42 64 147
AMLODIPINE BESYLATE-BENAZEPRIL 83 71 66 80
CIPROFLOXACIN HCL 82 79 67 62
AGGRENOX 78 56 68 222
CEPHALEXIN 78 68 68 56
LEXAPRO 76 64 70 179
CITALOPRAM HBR 76 76 70 19
DIOVAN 75 73 72 58
METHYLPHENIDATE HCL 75 50 72 393
LOSARTAN POTASSIUM 75 68 72 24
VIMPAT 73 73 75 333
PAROXETINE HCL 73 61 75 68
AZITHROMYCIN 73 65 75 37
HUMALOG 71 58 78 114
PRAVASTATIN SODIUM 71 71 78 10
VERAPAMIL ER 70 70 80 98
NITROFURANTOIN MONO-MACRO 67 55 81 151
BUSPIRONE HCL 67 66 81 127
CARVEDILOL 65 65 83 22
AMMONIUM LACTATE 65 63 83 282
AMITRIPTYLINE HCL 65 35 R 83 72
GALANTAMINE HBR 64 53 86 300
GLIPIZIDE 64 64 86 70
INDAPAMIDE 63 63 88 210
ALPRAZOLAM 61 50 89 124
DETROL LA 61 32 89 217
FLUOXETINE HCL 61 58 89 41
ESTRADIOL 60 59 R 92 181
CELEBREX 60 57 92 91
SUCRALFATE 60 56 92 183
SERTRALINE HCL 59 57 95 21
ACTOS 59 52 95 130
FLUTICASONE PROPIONATE 59 51 95 50
CEFTRIAXONE 58 53 98 213
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 52 98 73
KLOR-CON M20 58 54 98 54
TOPIRAMATE 58 48 98 165
BUPROPION XL 57 13 102 190
CRESTOR 57 56 102 30
MEGESTROL ACETATE 56 56 R 104 249
PREDNISONE 55 53 105 40
SINGULAIR 54 52 106 102
LIDOCAINE HCL 54 50 106 270
OXYBUTYNIN CHLORIDE 54 54 106 103
ULORIC 52 52 109 312
NAPROXEN 52 28 109 87
NITROFURANTOIN 52 52 109 253
PROPRANOLOL HCL 51 39 112 129
HYDROCHLOROTHIAZIDE 51 38 112 9
LUNESTA 50 50 114 309
FAMOTIDINE 50 48 114 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.